Identification of somatic TERT promoter mutations in familial nonmedullary thyroid carcinomas-Reference-Cited by-同舟云学术

Identification of somatic TERT promoter mutations in familial nonmedullary thyroid carcinomas

Published:2017-06-19 Issue:4 Volume:87 Page:394-399
ISSN:0300-0664
Container-title:Clinical Endocrinology
language:en
Short-container-title:Clin Endocrinol

Author:

Marques Inês J.¹²³,Moura Margarida M.¹,Cabrera Rafael⁴,Pinto António E.⁴,Simões-Pereira Joana¹³⁵,Santos Catarina⁶,Menezes Francisco D.⁷,Montezuma Diana⁷,Henrique Rui⁷⁸,Rodrigues Teixeira Manuel⁶⁸,Leite Valeriano¹³⁵,Cavaco Branca M.¹^ORCID

Affiliation:

1. Unidade de Investigação em Patobiologia Molecular (UIPM); Instituto Português de Oncologia de Lisboa Francisco Gentil; Lisboa Portugal

2. Chronic Diseases Research Centre (CEDOC); Universidade Nova de Lisboa; Lisboa Portugal

3. Nova Medical School/Faculdade de Ciências Médicas; Universidade Nova de Lisboa; Lisboa Portugal

4. Serviço de Anatomia Patológica; Instituto Português de Oncologia de Lisboa Francisco Gentil; Lisboa Portugal

5. Serviço de Endocrinologia; Instituto Português de Oncologia de Lisboa Francisco Gentil; Lisboa Portugal

6. Serviço de Genética; Instituto Português de Oncologia do Porto Francisco Gentil; Porto Portugal

7. Serviço de Anatomia Patológica; Instituto Português de Oncologia do Porto Francisco Gentil; Porto Portugal

8. Departamento de Patologia e Imunologia Molecular; Instituto de Ciências Biomédicas Abel Salazar; Universidade do Porto; Porto Portugal

Funder

Núcleo Regional Sul da Liga Portuguesa Contra o Cancro (NRS-LPCC)

Televisão Independente (TVI)

Instituto Português de Oncologia de Lisboa Francisco Gentil (IPOLFG)

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Endocrinology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cen.13375/fullpdf

Reference36 articles.

1. Familial nonmedullary thyroid carcinoma-clinical relevance and prognosis. A European multicenter study : ESES Vienna presentation;Hillenbrand;Langenbecks Arch Surg,2010

2. A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma;Ngan;J Natl Cancer Inst,2009

3. Identification of a novel germline FOXE1 variant in patients with familial non-medullary thyroid carcinoma (FNMTC);Pereira;Endocrine,2015

4. DICER1 mutations in familial multinodular goiter with and without ovarian Sertoli-Leydig cell tumors;Rio Frio;JAMA,2011

5. SRGAP1 Is a candidate gene for papillary thyroid carcinoma susceptibility;He;J Clin Endocrinol Metab,2013

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of novel candidate predisposing genes in familial nonmedullary thyroid carcinoma implicating DNA damage repair pathways;International Journal of Cancer;2024-09-09

2. Chromosomal localization of mutated genes in non-syndromic familial thyroid cancer;Frontiers in Oncology;2024-03-20

3. CHEK2 germline variants identified in familial nonmedullary thyroid cancer lead to impaired protein structure and function;Journal of Biological Chemistry;2024-03

4. Nonsyndromic Familial Thyroid Cancer;Endocrine Pathology;2022

5. Identification of SPRY4 as a Novel Candidate Susceptibility Gene for Familial Nonmedullary Thyroid Cancer;Thyroid;2021-09-01